{"transactions":[{"id":4636385,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-06T21:05:50.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":6893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":905993,"source":{"system":"sec-edgar","filing":"0001171843-26-006472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777962/000117184326006472/ownership.xml","form_type":"4"}},{"id":670892,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-09-01T22:12:25.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":899100,"source":{"system":"sec-edgar","filing":"0001171843-26-005844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005844/ownership.xml","form_type":"4"}},{"id":696897,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-08-04T21:02:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":5324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":893386,"source":{"system":"sec-edgar","filing":"0001171843-26-005208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005208/ownership.xml","form_type":"4"}},{"id":717290,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-07-02T21:05:48.000Z","date":"2026-07-02","kind":"grant","planned":false,"acquired":true,"shares":3378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":888062,"source":{"system":"sec-edgar","filing":"0001171843-26-004451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326004451/ownership.xml","form_type":"4"}},{"id":735864,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-16T21:03:05.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":153550,"price":5.21,"value":799995.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50."}],"balance_after":884684,"source":{"system":"sec-edgar","filing":"0001171843-26-004151","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326004151/ownership.xml","form_type":"4"}},{"id":756748,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:00:12.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":731134,"source":{"system":"sec-edgar","filing":"0001171843-26-003842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003842/ownership.xml","form_type":"4"}},{"id":758456,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43114,"kind":"person","name":"Marshall Patrick","position":1,"cik":"0001978257","reported_name":"Marshall Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:02:29.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":71666,"source":{"system":"sec-edgar","filing":"0001171843-26-003805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003805/ownership.xml","form_type":"4"}},{"id":758770,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43182,"kind":"person","name":"MacDonald Sean Arthur","position":1,"cik":"0001778981","reported_name":"MacDonald Sean Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:02:10.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":41054,"source":{"system":"sec-edgar","filing":"0001171843-26-003804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778981/000117184326003804/ownership.xml","form_type":"4"}},{"id":758455,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43113,"kind":"person","name":"Chypyha Joan","position":1,"cik":"0001978315","reported_name":"Chypyha Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:01:52.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":30029,"source":{"system":"sec-edgar","filing":"0001171843-26-003803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003803/ownership.xml","form_type":"4"}},{"id":758454,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43112,"kind":"person","name":"Weiler Peter J.","position":1,"cik":"0002066576","reported_name":"Weiler Peter J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-05-29T21:01:31.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":64609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":129609,"source":{"system":"sec-edgar","filing":"0001171843-26-003802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003802/ownership.xml","form_type":"4"}},{"id":758453,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2026-05-29T21:01:22.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":64609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":291479,"source":{"system":"sec-edgar","filing":"0001171843-26-003801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003801/ownership.xml","form_type":"4"}},{"id":758768,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:01:13.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":49417,"source":{"system":"sec-edgar","filing":"0001171843-26-003800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184326003800/ownership.xml","form_type":"4"}},{"id":758450,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:00:57.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001171843-26-003799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003799/ownership.xml","form_type":"4"}},{"id":758451,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-29T21:00:38.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":96913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":729463,"source":{"system":"sec-edgar","filing":"0001171843-26-003797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003797/ownership.xml","form_type":"4"}},{"id":759009,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43238,"kind":"person","name":"Liu Da David","position":1,"cik":"0002054265","reported_name":"Liu Da David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:00:19.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":24501,"source":{"system":"sec-edgar","filing":"0000921895-26-001502","document":"form412927027_05292026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054265/000092189526001502/form412927027_05292026.xml","form_type":"4"}},{"id":795321,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-02T01:01:45.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":632550,"source":{"system":"sec-edgar","filing":"0001171843-26-002942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326002942/ownership.xml","form_type":"4"}},{"id":810212,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-10T21:02:20.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":2578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":631391,"source":{"system":"sec-edgar","filing":"0001171843-26-002373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326002373/ownership.xml","form_type":"4"}},{"id":848271,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2026-03-11T21:02:18.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.57,"value":3140.0,"ownership":{"direct":true},"balance_after":226870,"source":{"system":"sec-edgar","filing":"0001171843-26-001490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001490/ownership.xml","form_type":"4"}},{"id":850409,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-10T21:02:16.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.5989,"value":6598.9,"ownership":{"direct":true},"balance_after":628813,"source":{"system":"sec-edgar","filing":"0001171843-26-001463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001463/ownership.xml","form_type":"4"}},{"id":855511,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-06T22:01:15.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.9,"value":39000.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":402702,"source":{"system":"sec-edgar","filing":"0001171843-26-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001390/ownership.xml","form_type":"4"}},{"id":857973,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-05T22:01:11.000Z","date":"2026-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.256,"value":42560.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":392702,"source":{"system":"sec-edgar","filing":"0001171843-26-001370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001370/ownership.xml","form_type":"4"}},{"id":860779,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-04T22:01:45.000Z","date":"2026-03-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":382702,"source":{"system":"sec-edgar","filing":"0001171843-26-001329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001329/ownership.xml","form_type":"4"}},{"id":865433,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-03T22:00:18.000Z","date":"2026-03-02","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.2796,"value":2279.6,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":372702,"source":{"system":"sec-edgar","filing":"0001171843-26-001302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001302/ownership.xml","form_type":"4"}},{"id":865432,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-03T22:00:18.000Z","date":"2026-03-02","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2,"value":4000.0,"ownership":{"direct":true},"balance_after":627813,"source":{"system":"sec-edgar","filing":"0001171843-26-001302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001302/ownership.xml","form_type":"4"}},{"id":873587,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.2232,"value":66696.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.2295 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":371702,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873586,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":10016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":625813,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873585,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":20571,"price":1.5789,"value":32479.5519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.58 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":615797,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873584,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:01:34.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":82236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025."}],"balance_after":595226,"source":{"system":"sec-edgar","filing":"0001171843-26-001266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001266/ownership.xml","form_type":"4"}},{"id":924554,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-02T22:01:02.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":11168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":512990,"source":{"system":"sec-edgar","filing":"0001171843-26-000567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326000567/ownership.xml","form_type":"4"}},{"id":950281,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-06T02:00:34.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":10444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":501822,"source":{"system":"sec-edgar","filing":"0001171843-26-000069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326000069/ownership.xml","form_type":"4"}},{"id":983256,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-12-02T23:01:01.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":8766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":491378,"source":{"system":"sec-edgar","filing":"0001171843-25-007725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007725/ownership.xml","form_type":"4"}},{"id":1005607,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-06T23:13:46.000Z","date":"2025-11-03","kind":"grant","planned":false,"acquired":true,"shares":6968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":482612,"source":{"system":"sec-edgar","filing":"0001171843-25-007107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007107/ownership.xml","form_type":"4"}},{"id":1024125,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-03T20:31:53.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":5908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":475644,"source":{"system":"sec-edgar","filing":"0001171843-25-006274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325006274/ownership.xml","form_type":"4"}},{"id":1041262,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-09-13T01:00:15.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":5981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":469736,"source":{"system":"sec-edgar","filing":"0001171843-25-005895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325005895/ownership.xml","form_type":"4"}},{"id":1076064,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-08-05T01:30:48.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":6802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":463755,"source":{"system":"sec-edgar","filing":"0001171843-25-005016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325005016/ownership.xml","form_type":"4"}},{"id":1094375,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-07-03T01:01:43.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":7186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":456953,"source":{"system":"sec-edgar","filing":"0001171843-25-004300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325004300/ownership.xml","form_type":"4"}},{"id":1127251,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43114,"kind":"person","name":"Marshall Patrick","position":1,"cik":"0001978257","reported_name":"Marshall Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:44:44.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":52666,"source":{"system":"sec-edgar","filing":"0001171843-25-003594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003594/ownership.xml","form_type":"4"}},{"id":1127248,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:29:54.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001171843-25-003592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003592/ownership.xml","form_type":"4"}},{"id":1127762,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:24:36.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":20001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":30417,"source":{"system":"sec-edgar","filing":"0001171843-25-003591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184325003591/ownership.xml","form_type":"4"}},{"id":1127250,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-06-03T01:21:02.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":7644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":449767,"source":{"system":"sec-edgar","filing":"0001171843-25-003590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003590/ownership.xml","form_type":"4"}},{"id":1127249,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-06-03T01:21:02.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":263200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 166,287 shares shall vest monthly in equal proportions over twelve (12) months, commencing on the grant date and (ii) 96,913 shares shall vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 166,287 shares shall vest monthly in equal proportions over twelve (12) months, commencing on the grant date and (ii) 96,913 shares shall vest in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":442123,"source":{"system":"sec-edgar","filing":"0001171843-25-003590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003590/ownership.xml","form_type":"4"}},{"id":1127763,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43182,"kind":"person","name":"MacDonald Sean Arthur","position":1,"cik":"0001778981","reported_name":"MacDonald Sean Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:19:57.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":20001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":22054,"source":{"system":"sec-edgar","filing":"0001171843-25-003589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778981/000117184325003589/ownership.xml","form_type":"4"}},{"id":1127247,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43113,"kind":"person","name":"Chypyha Joan","position":1,"cik":"0001978315","reported_name":"Chypyha Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:19:29.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":11029,"source":{"system":"sec-edgar","filing":"0001171843-25-003588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003588/ownership.xml","form_type":"4"}},{"id":1127246,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2025-06-03T01:18:41.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":207201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":224870,"source":{"system":"sec-edgar","filing":"0001171843-25-003587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003587/ownership.xml","form_type":"4"}},{"id":1127244,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43112,"kind":"person","name":"Weiler Peter J.","position":1,"cik":"0002066576","reported_name":"Weiler Peter J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-06-03T01:00:08.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001641172-25-013339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000164117225013339/ownership.xml","form_type":"4"}},{"id":1127965,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43238,"kind":"person","name":"Liu Da David","position":1,"cik":"0002054265","reported_name":"Liu Da David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T00:03:26.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":5501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":5501,"source":{"system":"sec-edgar","filing":"0000921895-25-001664","document":"form412927027_06022025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054265/000092189525001664/form412927027_06022025.xml","form_type":"4"}},{"id":1157129,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-05-06T21:28:21.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":178923,"source":{"system":"sec-edgar","filing":"0001171843-25-002829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325002829/ownership.xml","form_type":"4"}},{"id":1178908,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-04-03T21:25:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":5784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":172531,"source":{"system":"sec-edgar","filing":"0001171843-25-001997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325001997/ownership.xml","form_type":"4"}},{"id":1235280,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-04T01:00:55.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":6339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":166747,"source":{"system":"sec-edgar","filing":"0001171843-25-001217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325001217/ownership.xml","form_type":"4"}},{"id":1267457,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T22:02:30.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":10416,"price":1.92,"value":19998.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2025, the Reporting Person purchased in a private placement, 10,416 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share."}],"balance_after":10416,"source":{"system":"sec-edgar","filing":"0001171843-25-000869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184325000869/ownership.xml","form_type":"4"}},{"id":1266750,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-1 Convertible Preferred Shares","published_at":"2025-02-14T22:01:59.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 11, 2025, the Reporting Person purchased in a private placement, 100 shares of the Issuer's newly designated Series B-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share for an aggregate purchase price of $1.0 million. The Preferred Shares are immediately convertible at $1.92 per share, to the extent that after giving effect to such conversion the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Preferred Shares are perpetual and therefore have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Preferred Share is convertible at any time, at the option of the holder, into a number of common shares determined by dividing the stated value of the Preferred Share ($10,000 per share), plus all other amounts due in respect of such Preferred Share (excluding distributions), by the conversion price at the time of conversion."}],"balance_after":100,"derivative":{"exercise_price":1.92,"exercise_date":"2025-02-12","underlying":"Common Shares","underlying_shares":520833},"source":{"system":"sec-edgar","filing":"0001171843-25-000868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000868/ownership.xml","form_type":"4"}},{"id":1266749,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43114,"kind":"person","name":"Marshall Patrick","position":1,"cik":"0001978257","reported_name":"Marshall Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T22:01:23.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":41666,"price":1.92,"value":79998.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2025, the Reporting Person purchased in a private placement, 41,666 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share."}],"balance_after":41666,"source":{"system":"sec-edgar","filing":"0001171843-25-000867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000867/ownership.xml","form_type":"4"}},{"id":1283883,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-05T00:32:04.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":8264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":160408,"source":{"system":"sec-edgar","filing":"0001171843-25-000620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000620/ownership.xml","form_type":"4"}},{"id":1309792,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-06T23:01:31.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":8476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":152144,"source":{"system":"sec-edgar","filing":"0001171843-25-000056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000056/ownership.xml","form_type":"4"}},{"id":1344491,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-12-04T02:08:20.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":6420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":143668,"source":{"system":"sec-edgar","filing":"0001171843-24-006707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324006707/ownership.xml","form_type":"4"}},{"id":1368380,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-13T02:29:21.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":137248,"source":{"system":"sec-edgar","filing":"0001171843-24-006302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324006302/ownership.xml","form_type":"4"}},{"id":1378038,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2024-11-02T00:49:53.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":326560,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 30, 2024, the Reporting Person purchased in a private placement, (i) 150 shares of the Issuer's newly designated Series A-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share and (ii) warrants (the \"Warrants\") to purchase up to an aggregate of 326,560 common shares. The Preferred Shares are immediately convertible, and the Warrants are immediately exercisable, at $3.445 per share, in each case, to the extent that after giving effect to such conversion and/or exercise the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer. The Preferred Shares and the Warrants are being sold together in a fixed combination of one Preferred Share and a Warrant to purchase a number of common shares equal to 75% of the common shares underlying the Preferred Share at a combined purchase price of $10,272.13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pardeep Medicine Professional Corporation is wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":326560,"derivative":{"exercise_price":3.445,"exercise_date":"2024-10-30","expiration_date":"2029-10-30","underlying":"Common Stock","underlying_shares":326560},"source":{"system":"sec-edgar","filing":"0001171843-24-005964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005964/ownership.xml","form_type":"4"}},{"id":1378037,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A-1 Convertible Preferred Shares","published_at":"2024-11-02T00:49:53.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":150,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 30, 2024, the Reporting Person purchased in a private placement, (i) 150 shares of the Issuer's newly designated Series A-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share and (ii) warrants (the \"Warrants\") to purchase up to an aggregate of 326,560 common shares. The Preferred Shares are immediately convertible, and the Warrants are immediately exercisable, at $3.445 per share, in each case, to the extent that after giving effect to such conversion and/or exercise the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer. The Preferred Shares and the Warrants are being sold together in a fixed combination of one Preferred Share and a Warrant to purchase a number of common shares equal to 75% of the common shares underlying the Preferred Share at a combined purchase price of $10,272.13."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Preferred Shares are perpetual and therefore have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Preferred Share is convertible at any time, at the option of the holder, into a number of common shares determined by dividing the stated value of the Preferred Share ($10,000 per share), plus any accrued and unpaid dividends, by the conversion price at the time of conversion. Until the three-year anniversary of the day of issuance, holders of Preferred Shares are entitled to an annual return equal to 10% of the stated value per Preferred Share payable by the issuance of common shares at the conversion price upon a buy-back by the Issuer, liquidation or on conversion at the conversion price (calculated daily)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pardeep Medicine Professional Corporation is wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":150,"derivative":{"exercise_price":3.445,"exercise_date":"2024-10-30","underlying":"Common Stock","underlying_shares":435414},"source":{"system":"sec-edgar","filing":"0001171843-24-005964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005964/ownership.xml","form_type":"4"}},{"id":1393780,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-03T01:30:22.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":132618,"source":{"system":"sec-edgar","filing":"0001171843-24-005464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005464/ownership.xml","form_type":"4"}},{"id":1417478,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-09-04T00:00:18.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":3055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":129318,"source":{"system":"sec-edgar","filing":"0001171843-24-005045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005045/ownership.xml","form_type":"4"}},{"id":1442517,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-08-03T01:01:14.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":3317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":126263,"source":{"system":"sec-edgar","filing":"0001171843-24-004413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324004413/ownership.xml","form_type":"4"}},{"id":1459395,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-07-04T01:00:13.000Z","date":"2024-07-02","kind":"grant","planned":false,"acquired":true,"shares":4015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":122946,"source":{"system":"sec-edgar","filing":"0001654954-24-008617","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424008617/section16.xml","form_type":"4"}},{"id":1491491,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-06-05T01:01:06.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":4785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":118931,"source":{"system":"sec-edgar","filing":"0001654954-24-007354","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424007354/section16.xml","form_type":"4"}},{"id":1531671,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share","published_at":"2024-05-02T01:30:56.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":3083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":114146,"source":{"system":"sec-edgar","filing":"0001654954-24-005413","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424005413/section16.xml","form_type":"4"}},{"id":1552811,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-02T23:02:41.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":3253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":111063,"source":{"system":"sec-edgar","filing":"0001654954-24-004189","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424004189/section16.xml","form_type":"4"}},{"id":1561939,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-03-25T19:00:59.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":341702,"source":{"system":"sec-edgar","filing":"0001654954-24-003606","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495424003606/section16.xml","form_type":"4"}},{"id":1606321,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-01T23:20:34.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":2765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":107810,"source":{"system":"sec-edgar","filing":"0001654954-24-002509","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424002509/section16.xml","form_type":"4"}},{"id":1660903,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-03T02:30:45.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":2978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":105045,"source":{"system":"sec-edgar","filing":"0001654954-24-001264","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424001264/section16.xml","form_type":"4"}},{"id":1679794,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-12T22:30:48.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":2908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":102067,"source":{"system":"sec-edgar","filing":"0001654954-24-000528","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424000528/section16.xml","form_type":"4"}},{"id":1814706,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":110819,"kind":"person","name":"Lemieux Stephen","position":1,"cik":"0001983036","reported_name":"Lemieux Stephen","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-08-04T20:19:03.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":17400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units (\"RSUs\"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of certain compensation fees earned by Reporting Person. The number of RSUs was determined by dividing such fees by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023."}],"balance_after":17400,"source":{"system":"sec-edgar","filing":"0001654954-23-010168","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423010168/section16.xml","form_type":"4"}},{"id":1814705,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2023-08-04T20:18:59.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":93200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units (\"RSUs\"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023."}],"balance_after":123680,"source":{"system":"sec-edgar","filing":"0001654954-23-010167","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423010167/section16.xml","form_type":"4"}},{"id":1814704,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-08-04T20:18:55.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":99300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units (\"RSUs\"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023."}],"balance_after":694112,"source":{"system":"sec-edgar","filing":"0001654954-23-010166","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423010166/section16.xml","form_type":"4"}},{"id":1824012,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:56:14.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009605","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009605/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824011,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:46:08.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-23-009601","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009601/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824010,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43113,"kind":"person","name":"Chypyha Joan","position":1,"cik":"0001978315","reported_name":"Chypyha Joan","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:46:07.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009600","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009600/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824188,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:46:03.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009599","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495423009599/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824008,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:59.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009598","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009598/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824189,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43182,"kind":"person","name":"MacDonald Sean Arthur","position":1,"cik":"0001778981","reported_name":"MacDonald Sean Arthur","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:56.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009597","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778981/000165495423009597/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824009,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43114,"kind":"person","name":"Marshall Patrick","position":1,"cik":"0001978257","reported_name":"Marshall Patrick","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:48.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009596","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009596/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824007,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:45.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001654954-23-009594","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009594/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824006,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":110819,"kind":"person","name":"Lemieux Stephen","position":1,"cik":"0001983036","reported_name":"Lemieux Stephen","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:41.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001654954-23-009593","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009593/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824677,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:31:19.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001654954-23-009535","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009535/section16.xml","form_type":"4"}},{"id":1824676,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":110819,"kind":"person","name":"Lemieux Stephen","position":1,"cik":"0001983036","reported_name":"Lemieux Stephen","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:31:10.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001654954-23-009534","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009534/section16.xml","form_type":"4"}},{"id":1824674,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:31:08.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-23-009533","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009533/section16.xml","form_type":"4"}},{"id":1824675,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43114,"kind":"person","name":"Marshall Patrick","position":1,"cik":"0001978257","reported_name":"Marshall Patrick","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:55.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009532","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009532/section16.xml","form_type":"4"}},{"id":1824888,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43182,"kind":"person","name":"MacDonald Sean Arthur","position":1,"cik":"0001778981","reported_name":"MacDonald Sean Arthur","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:47.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009531","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778981/000165495423009531/section16.xml","form_type":"4"}},{"id":1824673,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43113,"kind":"person","name":"Chypyha Joan","position":1,"cik":"0001978315","reported_name":"Chypyha Joan","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:38.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009530","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009530/section16.xml","form_type":"4"}},{"id":1824672,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:33.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009529","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009529/section16.xml","form_type":"4"}},{"id":1824671,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43109,"kind":"person","name":"Olson Charles V","position":1,"cik":"0001663298","reported_name":"Olson Charles V","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:23.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009528","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009528/section16.xml","form_type":"4"}},{"id":1824887,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:18.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009527","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495423009527/section16.xml","form_type":"4"}},{"id":2056296,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":120760,"kind":"person","name":"van der Velden Peter","position":1,"cik":"0001778046","reported_name":"van der Velden Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94039,"kind":"organization","name":"Lumira Capital Investment Management Inc.","position":2,"cik":"0001702636","reported_name":"Lumira Capital Investment Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common share","published_at":"2023-01-11T20:42:13.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":12895,"price":2.6346,"value":33973.167,"ownership":{"direct":false,"nature":"Held by Lumira Capital II (International), L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is jointly filed by (i) Lumira Capital II, L.P. (\"LCII LP\"), (ii) Lumira Capital II (International), L.P. (\"LCII INT LP\"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":150275,"source":{"system":"sec-edgar","filing":"0001213900-23-002248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000121390023002248/ownership.xml","form_type":"4"}},{"id":2056295,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":120760,"kind":"person","name":"van der Velden Peter","position":1,"cik":"0001778046","reported_name":"van der Velden Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94039,"kind":"organization","name":"Lumira Capital Investment Management Inc.","position":2,"cik":"0001702636","reported_name":"Lumira Capital Investment Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common share","published_at":"2023-01-11T20:42:13.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":139450,"price":2.6346,"value":367394.97,"ownership":{"direct":false,"nature":"Held by Lumira Capital II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is jointly filed by (i) Lumira Capital II, L.P. (\"LCII LP\"), (ii) Lumira Capital II (International), L.P. (\"LCII INT LP\"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1625133,"source":{"system":"sec-edgar","filing":"0001213900-23-002248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000121390023002248/ownership.xml","form_type":"4"}},{"id":2056294,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":120760,"kind":"person","name":"van der Velden Peter","position":1,"cik":"0001778046","reported_name":"van der Velden Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94039,"kind":"organization","name":"Lumira Capital Investment Management Inc.","position":2,"cik":"0001702636","reported_name":"Lumira Capital Investment Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common share","published_at":"2023-01-11T20:42:13.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":12284,"price":2.6621,"value":32701.2364,"ownership":{"direct":false,"nature":"Held by Lumira Capital II (International), L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is jointly filed by (i) Lumira Capital II, L.P. (\"LCII LP\"), (ii) Lumira Capital II (International), L.P. (\"LCII INT LP\"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":163170,"source":{"system":"sec-edgar","filing":"0001213900-23-002248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000121390023002248/ownership.xml","form_type":"4"}},{"id":2056293,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":120760,"kind":"person","name":"van der Velden Peter","position":1,"cik":"0001778046","reported_name":"van der Velden Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94039,"kind":"organization","name":"Lumira Capital Investment Management Inc.","position":2,"cik":"0001702636","reported_name":"Lumira Capital Investment Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common share","published_at":"2023-01-11T20:42:13.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":132845,"price":2.6621,"value":353646.6745,"ownership":{"direct":false,"nature":"Held by Lumira Capital II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is jointly filed by (i) Lumira Capital II, L.P. (\"LCII LP\"), (ii) Lumira Capital II (International), L.P. (\"LCII INT LP\"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1764583,"source":{"system":"sec-edgar","filing":"0001213900-23-002248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000121390023002248/ownership.xml","form_type":"4"}},{"id":2124184,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":2119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":2119,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2124183,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":2119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":2119,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2124182,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43111,"kind":"person","name":"Brooks Michael J","position":1,"cik":"0001779126","reported_name":"Brooks Michael J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2022-11-04T19:27:10.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4239,"price":1.125,"value":4768.875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 4,239 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":30480,"source":{"system":"sec-edgar","filing":"0001654954-22-014747","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014747/section16.xml","form_type":"4"}},{"id":2124181,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4444,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":4444,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":4444},"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}},{"id":2124180,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":4444,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":4444,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":4444},"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}},{"id":2124179,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":122615,"kind":"person","name":"NIFFENEGGER KATHI","position":1,"cik":"0001620146","reported_name":"NIFFENEGGER KATHI","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-11-04T19:27:06.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":8888,"price":1.125,"value":9999.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":10715,"source":{"system":"sec-edgar","filing":"0001654954-22-014746","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422014746/section16.xml","form_type":"4"}}],"next_cursor":"2022-11-04T19:27:06.000000Z,2124179"}